https://www.businesswire.com/news/home/20240528507149/en/Leveragen-and-92Bio-Forge-Strategic-Alliance-to-Advance-Therapeutics-Using-Novel-Single-Domain-Antibody-Platform
Leveragen and 92Bio Forge Strategic Alliance to Advance Therapeutics Using Novel Single Domain...
Leveragen, Inc., a Boston-based early-stage biotech company developing next-generation genetic models for antibody discovery, announced today that it has ent...
https://leveragen.com/
Leveragen
Aug 20, 2025 - Leveragen is a Boston-based biotech company specializing in genetic engineering. We develop comprehensive solutions for genetic modeling, creating designer...